Asset Manager

Updated:

Halpern, Denny & Co

Halpern, Denny & Co is a asset manager based in Boston, founded 1991; the Altss profile covers its classification, headquarters, registration, AUM band, and...

Halpern, Denny & Co

Halpern, Denny & Co is a Boston-based private equity firm established in 1991. It focused on lower mid-market companies in the United States.

General information

Firm type

Asset Manager

Year founded

1991

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

John Halpern

Co-Founder & Managing Partner

John Denny

Co-Founder & Managing Partner

Sector focus

Enterprise SoftwareFinTechDigital HealthIndustrial TechHealthcare Services

Frequently asked questions

How does Halpern, Denny & Co source proprietary deal flow?

The firm sources almost entirely through its Boston and Northeast network, relying on founder-to-founder referrals and relationships built over three decades of early-stage investing. Halpern and Denny sit on boards rather than simply buying board observation rights, which embeds them into company networks that generate follow-on deal flow.

Does Halpern, Denny & Co participate in fund commitments or only direct deals?

The firm invests exclusively through direct equity positions in portfolio companies at the Seed and Series A stages. There is no public record of Halpern, Denny & Co making fund commitments, co-investing alongside growth funds, or operating a fund-of-funds sleeve.

What investment stages does Halpern, Denny & Co typically target?

Halpern, Denny & Co concentrates on Seed and Series A rounds, targeting companies that have a functional product and early customer traction but need capital and board-level operating guidance to scale. The firm does not publicly participate in later-stage growth rounds or pre-seed concept financing.

Which sectors does Halpern, Denny & Co explicitly avoid?

The firm does not invest in consumer internet, hardware-dependent cleantech, or capital-intensive biotech platforms. Its focus stays on enterprise-facing companies in software, data, applied AI, and healthcare IT — sectors where the founders' operating backgrounds directly inform underwriting and post-investment direction.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Boston Asset Manager profiles